TREX1 and Aicardi-Goutieres syndrome: Excitingly, we found that the specific KDM4B inhibitor JIB-04 can suppress cGAS activity by maintaining its methylation status, significantly improving autoimmune pathological features in both Trex1−/− mouse models and PBMCs from AGS patient.